Greater Toulouse Metropolitan Area
Associate Professor of Physiology at the Faculty of Pharmacy, University of Toulouse. My research focuses on metabolic targets involved in the challenges of cardio-oncology, using preclinical models, omics technologies, and artificial intelligence to better understand and mitigate the cardiovascular side effects of anticancer therapies. This work builds on previous experience in hematologic oncology, where I studied metabolic mechanisms underlying therapeutic resistance.
Physiologie et physiopathologie humaine à la Faculté des Sciences Pharmaceutiques de l'Université de Toulouse.
Biologist in the biochemistry sector of IFB (Toulouse - Purpan) : Prognostic markers discovery through the use of artificial intelligence tools. Post-doctoral researcher interested in metabolism, microenvironment and stem cell in the cardio-oncology field at I2MC (Toulouse - Rangueil). Teacher of the Faculty of Medicine (Licence / Master).
Main subject : Chemoresistance, metabolism and metastasis in Acute Myeloid Leukemia Others : Biology teacher in first, second and third years of medical/pharmaceutical school.
Main projects: - Stem cells, chemoresistance and metabolism in Acute Myeloid Leukemia; - IMODI consortium (development of PDX models; Public/private national partnership) for the AML project; Side projects: Collaborations with ENVT (characterization of the NSG mice), Stromalab and others.
Main Project: Antiatherogenic properties of Opuntia in ApoE-/- mice.
Development of a device using an innovative type of microscopy, the SPIM, to generate DNA damage in multicellular tumor spheroid model and imaging of deep cellular responses.